ESPR Stock Catalyst: Esperion Therapeutics Faces Unconfirmed Takeover Rumors

Jul 23, 2025 · 7:51pm ET

Rumors suggest a potential acquisition valued at $900 million.

Max move

+56.4%

High of day $2.08

Sparker timei

7:51pm ET

ESPR · Jul 23, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

Traders have been circulating unconfirmed rumors on social media about potential takeover interest in Esperion Therapeutics, Inc. (Nasdaq: ESPR). The rumored acquisition is speculated to be in the $900 million range.

The exact details and veracity of these rumors remain unclear, with no official filings or confirmations from Esperion Therapeutics or any potential acquirer. The company's free float stands at 235,009,000 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time ESPR sparks.

Download Sniper App →

Catch the next ESPR-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →